SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant

Cédric Garcia1,2, Baptiste Compagnon1,3, Agnès Ribes1,2

  • 1Inserm UMR1297 and Université Toulouse 3, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France.

Frontiers in Immunology
|October 13, 2023
PubMed
Abstract

Insights

The Omicron variant activates and desensitizes blood platelets, similar to the Delta variant. However, Omicron

Area of Science:

  • Hematology
  • Virology
  • Immunology

Background:

  • The emergence of the SARS-CoV-2 Omicron variant in November 2021 has led to global dominance of the COVID-19 pandemic.
  • Omicron exhibits numerous spike protein mutations, contributing to increased transmissibility and distinct clinical characteristics compared to previous variants.
  • While generally causing less severe disease, Omicron's specific impact on blood platelets remains largely uncharacterized.

Purpose of the Study:

  • To investigate and compare platelet behavior in severe COVID-19 patients infected with the Omicron variant versus the Delta variant.
  • To analyze platelet activation, responsiveness, phenotype, and viral presence within platelets.
  • To explore the direct effects of Omicron and Delta spike proteins on healthy platelet signaling pathways.

Main Methods:

  • Analysis of clinical and biological data from severe COVID-19 patients infected with Omicron (n=9) or Delta (n=11).
  • Utilized flow cytometry, confocal imaging, and electron microscopy to assess platelet characteristics and viral interactions.
  • Investigated the direct impact of isolated Omicron and Delta spike proteins on healthy platelet signaling.

Main Results:

  • Severe Omicron infection induced platelet activation, partial desensitization, and selective autophagy, with the virus detected within platelets.
  • Intraplatelet processing of Omicron viral components differed from Delta, evidenced by spike protein distribution and Rab7 colocalization.
  • Both Omicron and Delta spike proteins activated signaling pathways in healthy platelets, including AKT, p38MAPK, LIMK, and SPL76 phosphorylation, with distinct kinetics.

Conclusions:

  • Despite differing biological characteristics, Omicron, like Delta, causes platelet activation and desensitization in severe COVID-19.
  • The virus is present in platelets, triggering an innate selective autophagy response, but with altered intraplatelet processing mechanisms compared to Delta.
  • Mutations in the Omicron spike protein appear to modify virus-platelet interactions, influencing the innate immune response.